A leading North Rhine-Westphalian politician has been caught up in a scandal over a botched-up seminar test. The Christian Democrat failed to observe correct procedures for test papers as a visiting lecturer at RWTH Aachen University.

The German Defence Minister has denied claims she plagiarised parts of her doctoral thesis after a crowd-sourced plagiarism hunting website claimed to have found "elements of plagiarism" on 27 of the 62 pages of her 1990 dissertation.

German university heads have welcomed proposals by the Stifterverband – a network of foundations, businesses and individuals supporting the country’s higher education and research – for improved transparency in collaborations between universities and industry. The recommendations, issued in mid-April, stress the “responsibility of universities, as autonomous institutions, to regularly and appropriately inform the public about their collaborative projects with industry”.

In a surprise move, the president of the Johannes Gutenberg University of Mainz in Germany this week announced plans to overhaul controversial contracts governing the use of a €150 million donation from a philanthropic foundation. Critics have charged that the agreement gives the donor too much control over publishing decisions and faculty appointments at the school’s Institute of Molecular Biology, which the foundation helped create in 2009. The move, which could eventually influence similar funding arrangements at other German universities, only partly satisfies critics. They are pushing for greater transparency from universities and donors.

A German finance expert has warned that the country’s federal states could be entering a “dangerous race to the bottom” regarding legislation on transparency in cooperation between industry and higher education. He believes that cooperation agreements should be publicly accessible in order to guarantee academic freedom. The professor of finance and political economy at Aalen University, contested a contract between the University of Mainz and the Boehringer Ingelheim Foundation, the country’s largest pharmaceutical company that also engages in research.